CNS Pharmaceuticals【CNSP】銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

3.65

買値

3.40

売値

3.69

出来高

274

0.00 日の範囲 0.00

2.00 52 週間の範囲 975.00

時価総額

5.472M

前日終値

3.71

始値

時刻

3.6

最終取引時間

18:53:11

財務取引量

VWAP

平均取引量 (3 か月)

26,647,187

発行済株式数

1,499,251

配当利回り

PER

-0.30

1 株当たり利益 (EPS)

-12.57

歳入

純利益

-18.85M

CNS Pharmaceuticals Inc is a preclinical stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of ... CNS Pharmaceuticals Inc is a preclinical stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. 詳細を表示

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.cnspharma.com

本社

Carson City, Nevada, USA

設立

CNS Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker CNSP. The last closing price for CNS Pharmaceuticals was US$3.71. Over the last year, CNS Pharmaceuticals shares have traded in a share price range of US$ 2.00 to US$ 975.00.

CNS Pharmaceuticals currently has 1,499,251 shares in issue. The market capitalisation of CNS Pharmaceuticals is US$5.56 million. CNS Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.30.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.49	15.5063291139	3.16	4.6	3	253760	3.65071427	CS
4	0.38	11.620795107	3.27	4.6	2	341095	2.7311791	CS
12	-1.95	-34.8214285714	5.6	9.5	2	26647187	6.00731129	CS
26	-3.5	-48.951048951	7.15	18.495	2	20211328	6.30313748	CS
52	-898.85	-99.595567867	902.5	975	2	11658297	15.60864634	CS
156	-24896.35	-99.9853413655	24900	33562.5	2	4324515	1051.33997889	CS
260	-222746.35	-99.9983613917	222750	421500	2	2886188	15293.997299	CS

CNSP - Frequently Asked Questions (FAQ)

What is the current CNS Pharmaceuticals share price?

The current share price of CNS Pharmaceuticals is US$ 3.65

How many CNS Pharmaceuticals shares are in issue?

CNS Pharmaceuticals has 1,499,251 shares in issue

What is the market cap of CNS Pharmaceuticals?

The market capitalisation of CNS Pharmaceuticals is USD 5.56M

What is the 1 year trading range for CNS Pharmaceuticals share price?

CNS Pharmaceuticals has traded in the range of US$ 2.00 to US$ 975.00 during the past year

What is the PE ratio of CNS Pharmaceuticals?

The price to earnings ratio of CNS Pharmaceuticals is -0.3

What is the reporting currency for CNS Pharmaceuticals?

CNS Pharmaceuticals reports financial results in USD

What is the latest annual profit for CNS Pharmaceuticals?

The latest annual profit of CNS Pharmaceuticals is USD -18.85M

What is the registered address of CNS Pharmaceuticals?

The registered address for CNS Pharmaceuticals is 112 NORTH CURRY STREET, CARSON CITY, NEVADA, 89703

What is the CNS Pharmaceuticals website address?

The website address for CNS Pharmaceuticals is www.cnspharma.com

Which industry sector does CNS Pharmaceuticals operate in?

CNS Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
IMTEIntergrated Media Technology Ltd	US$ 1.07 (98.18%)	6.67M
JFBJFB Construction Holdings	US$ 6.90 (58.26%)	4
WINTWindtree Therapeutics Inc	US$ 2.25 (52.03%)	6.09M
MLGOMicroAlgo Inc	US$ 3.27 (29.76%)	5.15M
OCULOcular Therapeutix Inc	US$ 9.59 (27.70%)	23
ME23andMe Holding Company	US$ 1.05 (-41.34%)	57.83k
RCTRedCloud Holdings PLC	4.36 (-39.94%)	1.1k
RNAZTransCode Therapeutics Inc	US$ 0.7937 (-29.13%)	1.16M
BCAXBicara Therapeutics Inc	US$ 10.00 (-24.47%)	233
LVLULulus Fashion Lounge Holdings Inc	US$ 0.34 (-24.44%)	753
DMNDamon Inc	US$ 0.0407 (9.12%)	41.08M
AWHAspira Womans Health Inc	US$ 0.092 (4.66%)	8.45M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 9.68 (7.08%)	7.93M
BTOGBit Origin Ltd	US$ 0.2919 (11.97%)	7.28M
IMTEIntergrated Media Technology Ltd	US$ 1.07 (98.18%)	6.67M